OpenAI has officially begun testing ads in ChatGPT, and the executive behind them is working to convince users that not only is this new development in keeping with the company’s lofty goals, it’ll ...

OpenAI on Monday announced it’s beginning to test ads in the U.S. for users on its Free and Go subscription tiers. The newer Go plan is a low-cost subscription at $8 per month in the U.S. and was ...

Were you ready for some non-football consumerism? Ready or not, the Super Bowl’s annual blitz of commercials landed before and during the Seattle Seahawks and New England Patriots defense-first ...

It also pokes fun at OpenAI’s advertising plans in a new Super Bowl ad. It also pokes fun at OpenAI’s advertising plans in a new Super Bowl ad. is a news editor with over a decade’s experience in ...

OpenAI announced it will begin testing ads within ChatGPT in the coming weeks. Ads will begin to appear at the bottom of the chatbot's answers, and they will be clearly labeled, OpenAI said. OpenAI ...

OpenAI plans to start testing ads inside ChatGPT in the coming weeks, marking a significant shift for one of the world’s most widely used AI products. The company announced Friday that initial ad ...

ChatGPT may soon serve up ads for products it thinks you’d like to buy. OpenAI announced on Friday that it will be testing ads in its free version for logged-in, adult US users. It’s also rolling out ...

The best advertisements don’t just sell products — they are creative and make us think about the brand long after we’ve seen it. These campaigns employ a variety of tools to hook us, such as clever ...

The point of an advertisement is to sell a product; that’s how it’s always been. But how companies choose to capture customers’ attention has evolved greatly over the years. And if you’re interested ...

Opinions expressed by Entrepreneur contributors are their own. Not long ago, digital advertising was all about polish — sleek campaigns, flawless visuals and copy carefully crafted to persuade. But in ...

Regarding your editorial “HHS Tries to Stifle Corporate Speech” (Sept. 15): Ads are designed to persuade for profit, and when it comes to pharmaceuticals that promise to remove pain, enhance mood or ...

The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. President Trump and HHS Secretary Kennedy emphasize transparency and ...